Press release
Vitiligo Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight
To know in detail about the Vitiligo market outlook, drug uptake, treatment scenario, and epidemiology trends, click here @ Vitiligo Treatment Market Size [https://www.delveinsight.com/sample-request/vitiligo-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Vitiligo Market Report
* In June 2025, Incyte Corporation announced a study to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with non-segmental vitiligo.
* In June 2025, Pfizer conducted a study to learn about the safety and effects of the study medicine ritlecitinib for the possible treatment of non-segmental vitiligo. Vitiligo causes white patches on your skin when the cells that give your skin color are destroyed. Nonsegmental means that it can affect both sides of the body, such as both knees and both hands.
* In June 2025, Vyne Therapeutics Inc . organized a Phase 2b Trial Evaluating the Efficacy, Safety & Pharmacokinetics of VYN201 Gel in the Treatment of Non-Segmental Vitiligo.
* According to the findings, the United States accounted for around 60% of the Vitiligo diagnosed Prevalent Cases in the 7MM in 2023.
* In EU4 and the UK, Germany contributed the highest patient share of vitiligo, followed by the UK. Whereas Spain contributed to the lowest patient share.
* As per the estimates, there were 493,000 treated cases of vitiligo in the 7MM in 2023.
* The leading Vitiligo Companies such as Incyte, AbbVie, Pfizer, Clinuvel, Inc., Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotechnologies, Temprian Therapeutics, Aclaris Therapeutics, TWi Biotechnology, Dermavant Sciences, Amgen, Pfizer, Incyte Corporation , and others
* Promising Vitiligo Pipeline Therapies such as OPZELURA (ruxolitinib cream), RINVOQ (upadacitinib), Ritlecitinib, Afamelanotide, Phimelanotide, BNZ-1, TAGX-0003, TT-01, ATI-1777, AC-1101, Cerdulatinib, AMG 714, Ritlecitinib, Ruxolitinib , and others.
Get a Free sample for the Vitiligo Therapeutics Market Report @ Vitiligo Drugs Market [https://www.delveinsight.com/sample-request/vitiligo-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Vitiligo Epidemiology Segmentation in the 7MM
* Vitiligo Prevalence Cases
* Vitiligo Type-specific Cases
* Vitiligo Diagnosed Prevalent Cases
* Vitiligo Treated Cases
Download the report to understand which factors are driving Vitiligo epidemiology trends @ Vitiligo Prevalence [https://www.delveinsight.com/sample-request/vitiligo-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Vitiligo Marketed Drugs
* OPZELURA (ruxolitinib cream): Incyte
In July 2024, the US FDA approved a groundbreaking treatment for vitiligo, a chronic immune-mediated skin disorder characterized by depigmented white patches on the skin. The newly approved drug, OPZELURA, is a topical Janus kinase (JAK) inhibitor called ruxolitinib. This approval marks a significant milestone, as OPZELURA is the first FDA-approved pharmacologic treatment specifically designed to address repigmentation in vitiligo patients, particularly those with nonsegmental vitiligo, the most common form of the condition. OPZELURA works by targeting JAK1 and JAK2 receptors to decrease interferon gamma signaling by immune cells, thereby halting the destruction of melanocytes responsible for skin color.
Vitiligo Emerging Drugs
* RINVOQ (upadacitinib): Abbvie
Upadacitinib (ABT-494) is a JAK1 selective inhibitor being investigated to treat alopecia areata, ankylosing spondylitis, atopic dermatitis, axial SpA, Crohn's disease, giant cell arteritis, hidradenitis suppurativa (HS), psoriatic arthritis, rheumatoid arthritis, systemic lupus erthematosus (SLE), Takayasu arteritis, ulcerative colitis, and vitiligo. Currently, the drug is in Phase III for the treatment of vitiligo, for which primary completion date is December 2024. At the 2024 AAD Annual Meeting, late-breaking data showed that upadacitinib demonstrated clinically meaningful repigmentation of extensive vitiligo after 52 weeks, potentially offering a new and effective systemic treatment for non-segmental vitiligo.
* LITFULO (Ritlecitinib): Pfizer
LITFULO (ritlecitinib) is considered a kinase inhibitor, meaning it prevents kinases, which are certain proteins in the immune system, from working properly. This in turn blocks the immune pathways that are thought to contribute to the development of autoimmune diseases, resulting in symptom improvements, such as repigmentation or stopping of disease progression in vitiligo. Currently, there is a Phase III Vitiligo Clinical Trial underway with an estimated completion date in June 2025. Depending on the results of that trial, ritlecitinib may be approved for vitiligo treatment.
Discover more about therapies set to grab major Vitiligo market share @ Vitiligo Clinical Trials Assessment [https://www.delveinsight.com/sample-request/vitiligo-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Vitiligo Treatment Market
The Vitiligo Treatment Market Landscape is undergoing rapid transformation, marked by significant advancements anticipated in 2024 and beyond. With the introduction of FDA-approved topical therapies and the emergence of oral JAK inhibitors, dermatology is experiencing remarkable progress in managing this complex condition. These developments signify a promising future for vitiligo patients, reflecting the evolving strategies aimed at enhancing treatment efficacy and patient outcomes. Key Vitiligo Companies such as AbbVie, Incyte, Pfizer, and others are evaluating their lead candidates in different stages of clinical development, respectively. They aim to investigate their products for the treatment of vitiligo. Vitiligo treatment typically involves a combination approach, incorporating various topical therapies such as steroids, vitamin D analogues, and calcineurin inhibitors. While mono-therapy topicals have shown improvement, the most effective treatment strategy often involves a combination of phototherapy, oral antioxidants, and both oral and topical medications. This multifaceted approach addresses the complex nature of vitiligo and maximizes therapeutic outcomes. Driven by rising awareness and new treatment options, the vitiligo market is poised for steady growth in the coming years.
Vitiligo Drugs and Companies
* OPZELURA (ruxolitinib cream): Incyte
* RINVOQ (upadacitinib): AbbVie
* Ritlecitinib: Pfizer
* Afamelanotide: Clinuvel, Inc.
* Phimelanotide - Clinuvel Pharmaceuticals
* BNZ-1: Bioniz Therapeutics
* TAGX-0003: TAGCyx Biotechnologies
* TT-01: Temprian Therapeutics
* ATI-1777: Aclaris Therapeutics
* AC-1101: TWi Biotechnology
* Cerdulatinib: Dermavant Sciences
* AMG 714: Amgen
* Ritlecitinib: Pfizer
* Ruxolitinib: Incyte Corporation
Vitiligo Market Drivers
* Increasing awareness
* Demand for novel therapies
* Large patient pool and better healthcare infrastructure
Vitiligo Market Barriers
* Patient compliance
* Chronic nature of the disease and long-term therapy
* Lack of adequate financial assistance & stringent regulatory procedure
Download DelveInsight's latest report to gain strategic insights into upcoming Vitiligo Therapies and key Vitiligo Developments @ Vitiligo Market Drivers and Barriers, and Future Perspectives [https://www.delveinsight.com/sample-request/vitiligo-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Vitiligo Market Report
* Coverage- 7MM
* Study Period- 2020-2034
* Vitiligo Companies- Incyte, AbbVie, Pfizer, Clinuvel, Inc., Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotechnologies, Temprian Therapeutics, Aclaris Therapeutics, TWi Biotechnology, Dermavant Sciences, Amgen, Pfizer, Incyte Corporation, and others
* Vitiligo Pipeline Therapies- OPZELURA (ruxolitinib cream), RINVOQ (upadacitinib), Ritlecitinib, Afamelanotide, Phimelanotide, BNZ-1, TAGX-0003, TT-01, ATI-1777, AC-1101, Cerdulatinib, AMG 714, Ritlecitinib, Ruxolitinib, and others.
* Vitiligo Therapeutic Assessment: Vitiligo current marketed and emerging therapies
* Vitiligo Market Dynamics: Vitiligo market drivers and Vitiligo market barriers
* Vitiligo Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Vitiligo Unmet Needs, KOL's views, Analyst's views, Vitiligo Market Access and Reimbursement
Table of Contents
1 Key Insights
2 Vitiligo Market Report Introduction
3 Vitiligo Executive Summary
4 Key Events
5 Vitiligo Epidemiology and Market Forecast Methodology
6 Vitiligo Market Overview at a Glance
7 Disease Background and Overview: Vitiligo
8 Vitiligo Treatment and Management
9 Vitiligo Epidemiology and Patient Population in the 7MM
10 Patient Journey
11 Vitiligo Marketed Therapies
12 Vitiligo Emerging Therapies
13 Vitiligo: Seven Major Market Analysis
14 Vitiligo Unmet Needs
15 Vitiligo SWOT Analysis
16 Vitiligo KOL Views
17 Vitiligo Market Access and Reimbursement
18 Appendix
19 DelveInsight Capabilities
20 Disclaimer
21 About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=vitiligo-therapeutics-market-size-in-7mm-is-expected-to-grow-at-a-decent-cagr-by-2034-estimates-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/vitiligo-market
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vitiligo Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight here
News-ID: 4076443 • Views: …
More Releases from ABNewswire
Denver's Best Appliance Repair Responds to Rising Demand for Emergency Appliance …
Denver's Best Appliance Repair expands emergency services across the Denver metro with same-day repairs, 7-day availability, 5-year parts warranty, and professional licensed technicians serving residential and commercial clients.
Household appliance failures don't follow a schedule. When a refrigerator stops cooling in the middle of summer or a washing machine floods a basement on a Sunday evening, families need immediate help. Denver's Best Appliance Repair has responded to this growing need by…
Oak Hill Clinic Reaches 30,000 Client Milestone with Results-Driven Deep Tissue …
Deep Relief in Oak Hill, Austin, has served 30,000 clients through specialized massage, chiropractic, and acupuncture care. The clinic accepts insurance and focuses on results-driven treatments for pain relief.
Deep Relief, an Oak Hill-based wellness clinic, has achieved a significant milestone by serving more than 30,000 clients seeking Relief from chronic pain, muscle tension, and mobility issues. The clinic's success stems from its commitment to advanced, results-focused bodywork that goes beyond…
Vertex Fleet Expands Nationwide Network to Combat Growing Trailer Drop Yard Shor …
Vertex Fleet announces major expansion of secure parking facilities nationwide, addressing the critical shortage of commercial vehicle storage with 15+ new locations featuring 24/7 security and technology-driven access.
The freight and logistics industry faces a mounting crisis as demand for secure parking spaces continues to outpace supply across the United States. Vertex Fleet [https://www.vertexfleet.com/], a leading provider of industrial outdoor storage solutions, has announced significant expansion plans to address this critical…
HVAC in Denver Sees Service Enhancement as Denver's Best Heating and AC Repair L …
Denver's Best Heating and AC Repair expands 24/7 emergency services across 23 metro cities, offering A+ rated heating, cooling, and commercial HVAC solutions with rapid response times and multi-brand expertise.
Denver's Best Heating and AC Repair [https://www.denversbestheatingandacrepair.com/]has expanded its service capabilities to meet growing demand for reliable heating and cooling solutions across the Denver Metro area. The A+ rated contractor now provides 24/7 emergency response services to 23 cities, addressing critical…
More Releases for Vitiligo
Organic Care Australia Introduces 'Vitiligo Organics' - A Revolutionary Herbal T …
Image: https://www.getnews.info/uploads/39ec7fd227c4937add1acccc27f32c1b.jpg
Organic Care Australia proudly announced the launch of 'Vitiligo Organics' in 2009, a revolutionary herbal treatment that promises new hope for individuals living with vitiligo, a condition characterized by the loss of skin pigmentation resulting in white patches. This innovative product represents a significant breakthrough in the management of vitiligo, offering a natural, effective solution for those who have long sought an alternative to conventional treatments.
Vitiligo impacts millions worldwide,…
Vitiligo Treatment Market - Unleash Your True Colors: Breakthrough Vitiligo Trea …
Newark, New Castle, USA: The "Vitiligo Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Vitiligo Treatment Market: https://www.growthplusreports.com/report/vitiligo-treatment-market/7780
This latest report researches the industry structure, sales, revenue,…
Vitiligo - Drug Pipeline Landscape, 2022
Vitiligo is a chronic disorder that causes patches of skin to lose pigment or color, when melanocytes are attacked and destroyed, causing the skin to turn a milky-white color. There are two types of vitiligo such as nonsegmental or generalized vitiligo and segmental vitiligo. Nonsegmental or generalized vitiligo happens when the white patches appear symmetrically on both sides of body, such as on both hands or both knees. Segmental vitiligo…
Vitiligo Treatment Market: Rising Impressive Business Opportunities Analysis For …
Vitiligo Treatment Market Report 2022: Industry aims to provide an overview of the industry through detailed market segmentation. The report offers thorough information about the overview and scope of the market along with its drivers, restraints, and trends. This report is designed to include both qualitative and quantitative aspects of the industry in each region and country participating in the study.
Get a Sample PDF of the Report @ https://impeccablemarketresearch.com/enquiry/request-sample-pdf/14636671?utm_source=Openpr&utm_medium=Shubhamko
…
Vitiligo Skin Disorder
Vitiligo Skin Disorder
Vitiligo skin disorder is a skin condition in which white patches on the skin are formed due to malfunctioning of melanocytes, cells that promote pigmentation. http://www.curevitiligooil.com/Vitiligo-Skin-Disorder.htmlThe start of this disease and the grimness of pigment loss vary from person to person. People who have light skin usually witness the loss of pigment in summers because the contrast between depigmented skin and sunburned skin appears distinctive. On the other…
Vitiligo Symptoms
Vitiligo produces macules which are small areas of different skin color. The skin disorder may also produce patches which are flat, pale or white and can't be felt with fingers. (http://www.curevitiligooil.com/Vitiligo-Symptoms.html). These marks frequently expand to form very large, irregularly-shaped areas with no pigmentation. Typically, these are painless and do not itch. The cause of vitiligo symptoms is not known, but autoimmunity may be a factor. Since it is a…
